Sigilon
is a Massachusetts-based biopharmaceutical company that researches and develops cell therapies for the treatment of chronic diseases... Read moreSigilon
is a Massachusetts-based biopharmaceutical company that researches and develops cell therapies for the treatment of chronic diseases... Read more
News
Aug 17, 2023
Pharamceutical Technology
Sigilon: Signal: Tweets of the week focus on Eli Lilly's most recent acquisitions
Aug 14, 2023
BioSpace
Sigilon: Lilly Completes Acquisition of Sigilon Therapeutics
Aug 11, 2023
MarketScreener
Sigilon: Sigilon Therapeutics, Inc.(NasdaqGS:SGTX) dropped from S&P TMI Index
Aug 11, 2023
MarketScreener
Sigilon: Sigilon Therapeutics : Acquisition/Asset Disposal - Form 8-K
Aug 07, 2023
Owler
Sigilon Therapeutics, Inc.: Sigilon's revenue changed from $14.64M in Mar 2023 to $17.65M in Jun 2023
Jul 21, 2023
centralcharts
Press Release: Sigilon : SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX
Jul 20, 2023
GlobalNewswire
Press Release: Sigilon : BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE - AEL), Amedisys, Inc. (Nasdaq - AMED), Sigilon Therapeutics, Inc (Nasdaq - SGTX)
Jul 13, 2023
Endpoints News
Sigilon: Sigilon outlines negotiations that led to Eli Lilly buyout
Jul 05, 2023
centralcharts
Press Release: Sigilon : Moore Kuehn Encourages AMED, KLR, SGTX, and WAKE Investors to Contact Law Firm
Jul 04, 2023
Global Legal Chronicle
Sigilon: Eli Lilly's Acquisition of Sigilon Therapeutics
Sigilon Competitors
1
2
3
4
5
6
7
8